Literature DB >> 19169967

Amyloid angiopathy in idiopathic Parkinson's disease. Immunohistochemical and ultrastructural study.

Ewa Bertrand1, Eliza Lewandowska, Tomasz Stepień, Grazyna M Szpak, Elzbieta Pasennik, Joanna Modzelewska.   

Abstract

The prevalence of cerebral amyloid angiopathy (CAA) and its association with intellectual decline in idiopathic Parkinson's disease (iPD) remain unclear. To identify the role of CAA in iPD dementia the prevalence and severity of CAA were investigated, with particular respect to changes in vessel wall structure. Twenty-eight autopsy Parkinsonian brains and fourteen age-matched controls, post-mortem revised histopathologically for the presence of alpha-synuclein and Alzheimer's disease (AD)-type pathology, using standardized clinico-neuropathological criteria, underwent further investigation. Histological, immunohistochemical staining methods with antibodies to amyloid beta-peptide, alpha-actin, collagen III, collagen IV and CD34 as well as ultrastructural methods were used. The findings showed that the prevalence of CAA in the iPD cohort was higher (53%) than in controls (28%). CAA occurred more frequently in the iPD+AD (70%) sub-set than in the iPD-AD (44%) one. The progression of CAA was differentiated, with predominance of mild stage. Diminished smooth muscle actin and collagen IV expression in the vascular media with concomitant collagen III positive immunoreactivity in the intima were observed only in very severe CAA. Ultrastructural assay revealed degenerative changes in vessel smooth muscle cells and thickening of their basement membrane with the focal accumulation of amyloid fibres and fibrillar collagen in both iPD -AD and iPD+AD cases, but the most severe CAA-type changes were visible in the iPD+AD sub-set. The same type of immunoreactivity (Abeta42 positive and Abeta40 positive) of arterial CAA and parenchymal neuritic plaques, as well as capillary CAA and diffuse plaques (Abeta42 positive and Abeta40 negative), may indicate pathogenic similarities and differences between both types of degenerative changes on the one hand and time-different changes or local different processing of amyloid precursor protein on the other.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19169967

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  13 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

Review 2.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

3.  Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-04-29       Impact factor: 3.575

Review 4.  Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions.

Authors:  Jordan B Jahrling; Remi-Martin Laberge
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

Review 5.  Cerebral Microvascular Injury: A Potentially Treatable Endophenotype of Traumatic Brain Injury-Induced Neurodegeneration.

Authors:  Danielle K Sandsmark; Asma Bashir; Cheryl L Wellington; Ramon Diaz-Arrastia
Journal:  Neuron       Date:  2019-08-07       Impact factor: 17.173

6.  TOR-dependent cerebrovascular aging in Alzheimer's disease.

Authors:  Jordan B Jahrling; Veronica Galvan
Journal:  Curr Trends Neurol       Date:  2014

Review 7.  Neuropathological basis of nonmotor manifestations of Parkinson's disease.

Authors:  Charles H Adler; Thomas G Beach
Journal:  Mov Disord       Date:  2016-03-31       Impact factor: 10.338

Review 8.  Amyloidosis in Retinal Neurodegenerative Diseases.

Authors:  Ambra Masuzzo; Virginie Dinet; Chelsea Cavanagh; Frederic Mascarelli; Slavica Krantic
Journal:  Front Neurol       Date:  2016-08-08       Impact factor: 4.003

9.  Cerebral amyloid angiopathy distribution in older people: A cautionary note.

Authors:  Vafa Alakbarzade; Jonathan Mr French; David R Howlett; Johannes Attems; Paul T Francis; Sarah Stratton; Camilla N Clark; Anthony C Pereira; Atticus H Hainsworth
Journal:  Alzheimers Dement (N Y)       Date:  2021-02-16

Review 10.  On the Role of Platelet-Generated Amyloid Beta Peptides in Certain Amyloidosis Health Complications.

Authors:  Mikhail Inyushin; Astrid Zayas-Santiago; Legier Rojas; Lilia Kucheryavykh
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.